| Ronald W Yeh, MD | |
|
11800 Ne 128th St, Suite 100, Kirkland, WA 98034-7201 | |
| (425) 899-4500 | |
| (425) 899-4510 |
| Full Name | Ronald W Yeh |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 24 Years |
| Location | 11800 Ne 128th St, Kirkland, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033162334 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD00045727 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Swedish Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
New technology from Purdue University and Indiana University School of Medicine innovators may one day help patients who suffer devastating vocal injuries from surgery on the larynx.
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today, building on its rapid response to the COVID-19 health crisis, approved allocating up to $50 million in additional funding for new projects in PCORI's COVID-19 funding opportunities, as well as enhancements to existing PCORI-funded studies.
The state is inviting public comment on how dentists fit with reforms of the Oregon Health Plan. Last week, two lawmakers and a dental executive submitted a petition to the Oregon Health Authority asking that dental care remain separate until 2017 from the state's new coordinated care organizations (CCOs), provider networks set up to integrate services, manage spending and reward prevention in the care of low-income members of the Medicaid-funded system.
Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.
Party leaders will be touting the health overhaul passed two years ago, as well as efforts to expand contraception coverage. In addition, the platform looks ahead at issues such as health disparities, public health and HIV, Politico Pro reports.
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
New technology from Purdue University and Indiana University School of Medicine innovators may one day help patients who suffer devastating vocal injuries from surgery on the larynx.
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today, building on its rapid response to the COVID-19 health crisis, approved allocating up to $50 million in additional funding for new projects in PCORI's COVID-19 funding opportunities, as well as enhancements to existing PCORI-funded studies.
The state is inviting public comment on how dentists fit with reforms of the Oregon Health Plan. Last week, two lawmakers and a dental executive submitted a petition to the Oregon Health Authority asking that dental care remain separate until 2017 from the state's new coordinated care organizations (CCOs), provider networks set up to integrate services, manage spending and reward prevention in the care of low-income members of the Medicaid-funded system.
Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.
Party leaders will be touting the health overhaul passed two years ago, as well as efforts to expand contraception coverage. In addition, the platform looks ahead at issues such as health disparities, public health and HIV, Politico Pro reports.
› Verified 8 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689612954 PECOS PAC ID: 0244138196 Enrollment ID: O20031230000187 |
News Archive
New technology from Purdue University and Indiana University School of Medicine innovators may one day help patients who suffer devastating vocal injuries from surgery on the larynx.
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today, building on its rapid response to the COVID-19 health crisis, approved allocating up to $50 million in additional funding for new projects in PCORI's COVID-19 funding opportunities, as well as enhancements to existing PCORI-funded studies.
The state is inviting public comment on how dentists fit with reforms of the Oregon Health Plan. Last week, two lawmakers and a dental executive submitted a petition to the Oregon Health Authority asking that dental care remain separate until 2017 from the state's new coordinated care organizations (CCOs), provider networks set up to integrate services, manage spending and reward prevention in the care of low-income members of the Medicaid-funded system.
Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.
Party leaders will be touting the health overhaul passed two years ago, as well as efforts to expand contraception coverage. In addition, the platform looks ahead at issues such as health disparities, public health and HIV, Politico Pro reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald W Yeh, MD 125 16th Ave E, Seattle, WA 98112-5211 Ph: (206) 326-3000 | Ronald W Yeh, MD 11800 Ne 128th St, Suite 100, Kirkland, WA 98034-7201 Ph: (425) 899-4500 |
News Archive
New technology from Purdue University and Indiana University School of Medicine innovators may one day help patients who suffer devastating vocal injuries from surgery on the larynx.
The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today, building on its rapid response to the COVID-19 health crisis, approved allocating up to $50 million in additional funding for new projects in PCORI's COVID-19 funding opportunities, as well as enhancements to existing PCORI-funded studies.
The state is inviting public comment on how dentists fit with reforms of the Oregon Health Plan. Last week, two lawmakers and a dental executive submitted a petition to the Oregon Health Authority asking that dental care remain separate until 2017 from the state's new coordinated care organizations (CCOs), provider networks set up to integrate services, manage spending and reward prevention in the care of low-income members of the Medicaid-funded system.
Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.
Party leaders will be touting the health overhaul passed two years ago, as well as efforts to expand contraception coverage. In addition, the platform looks ahead at issues such as health disparities, public health and HIV, Politico Pro reports.
› Verified 8 days ago
David H Lee, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11800 Ne 128th St, Suite 100, Kirkland, WA 98034 Phone: 425-899-4500 Fax: 425-899-4510 | |
Mark R Vossler, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 | |
William S Getchell, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 | |
Erin-siobhain Ross Currin, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St, Kirkland, WA 98034 Phone: 425-899-3181 | |
Dr. James A. Lund, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12910 Totem Lake Blvd Ne, Suite 101, Kirkland, WA 98034 Phone: 425-814-5000 | |
Dr. Sarah P. Rougier, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St # Ms 105, Kirkland, WA 98034 Phone: 425-899-2563 |